Table 1– Summary of cross-sectional studies that compared clinical characteristics in chronic obstructive pulmonary disease subjects with and without chronic cough and sputum production
First author [ref.]PopulationSubjects nChronic cough and/or sputumCurrent smokersExacerbations per patient per yearDyspnoea MMRC scaleHRQoL
Cough + sputumNo cough + sputumCough + sputumNo cough + sputumCough + sputumNo cough + sputumCough + sputumNo cough + sputum
Agusti [2]Clinic based (multinational)216134.6GOLD 2: 52*
GOLD 3: 46*
GOLD 4: 37*
GOLD 2: 31
GOLD 3: 3
GOLD 4:21
GOLD 2: 0.6±1.1
GOLD 3: 1.0±1.2
GOLD 4: 1.2±1.6
GOLD 2: 0.7±1.0
GOLD 3: 1.0±1.4
GOLD 4: 1.2±1.3
GOLD 2: 1.5±1.0*
GOLD 3: 1.8±1.0
GOLD 4: 2.4±1.0
GOLD 2: 1.3±1.0
GOLD 3: 1.8±1.1
GOLD 4: 2.3±1.0
SGRQ-C
GOLD 2:50.3±18.8*
GOLD 3: 58.8±17.6*
GOLD 4:65.0±16.5*
SGRQ-C
GOLD 2:38.9± 20.5
GOLD 3:51.2±18.2 GOLD 4:59.4±15.2
Burgel [15]Clinic based (France)43374.128*182.2±2.2*1.0±1.2N/AN/AN/AN/A
Kim [16]Clinic-based (USA)106127.348*271.2±1.6*0.63±1.13 (2–4)*2 (1–3)SGRQ 62.5±19.0*SGRQ 38.0±22.4
Montes de Oca [14]Population based (Latin America)75914.4#47*325.422.66Present: 76*Present: 47SF-12 physical score 44.6±1.01*SF-12 physical score 49.5±0.36
Lu [17]Population based (China)166830.048*37N/AN/AMMRC >2: 64*MMRC >2: 29N/AN/A
  • Data are presented as %, mean±sd or median (interquartile range), unless otherwise specified. MMRC: modified Medical Research Council; HRQoL: heath-related quality of life; GOLD: Global initiative for chronic Obstructive Lung Disease; SGRQ: St. George's Respiratory Questionnaire; SGRQ-C: chronic obstructive pulmonary disease version of the SGRQ; N/A: not applicable; SF-12: Short Form-12 questionnaire. #: phlegm most days, at least 3 months a year for ≥2 yrs. *: p<0.05.